Skip to main content
. Author manuscript; available in PMC: 2011 Jul 1.
Published in final edited form as: Glia. 2010 Jul;58(9):1031–1041. doi: 10.1002/glia.20984

Figure 10.

Figure 10

β-catenin siRNA suppression of IGF-I-promoted oligodendrocytes survival. Oligodendrocytes were pre-treated with β-catenin siRNA (βCat) or a negative control siRNA (neg siRNA), as well as 100 ng/ml of IGF-I, as previously described in Figure 9. Values represent mean ± SE of 4 samples. *, P < 0.001, compared to non-IGF-I treated controls. ^, P < 0.01, compared to IGF-I treated cells that were pre-transfected with negative control siRNA.